Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Focal Point Contact Information |
Salutation: |
Dr. |
First Name: |
NAOMI |
Last Name: |
KOMATSU |
Title: |
PUBLIC HEALTH SPECIALIST |
Email: |
nkomatsu@prefeitura.sp.gov.br |
Phone: |
55 11 3397 8307 |
|
Alternate Focal Point Contact Information |
Salutation: |
Mrs |
First Name: |
Eri |
Last Name: |
Ishimoto |
Title: |
public health specialist |
Email: |
eishimoto@prefeitura.sp.gov.br |
Phone: |
55 11 3397 8308 |
|
General Information |
Board Constituency: |
Countries |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Governmental Organization |
Organization Type - Secondary: |
None |
Organization Description: |
SAO PAULO CITY TB CONTROL PROGRAM - MUNICIPAL HEALTH SECRETARY - 11 MILLION OF INHABITANTS - MANAGEMENT OF A HEALTH SYSTEM COVERING 510 HEALTH CENTERS, 50 PUBLIC HOSPITALS, 17 HIV/TB AMBULATORIES AND 52 LABORATORIES. |
|
Do you know about the UNHLM declaration: |
|
Specializations / Areas of Work |
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information |
Total number of staff in your organization: |
6 - 10 |
Number of full-time staff who are directly involved with TB: |
1 - 5 |
Number of part-time staff who are directly involved with TB: |
1 - 5 |
Number of volunteers who are directly involved with TB: |
0 |
|
How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Involvement in Stop TB Working Groups |
|
Are you a member of a Stop TB national partnership: |
Brazil |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
By providing trainning, planning activities, organising the laboratory network, monitoring and evaluating data and actions. |
|
Geographical Reach |
Which country is your headquarters located in: |
Brazil |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Brazil |
Contribution |
Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
TB Care Delivery: Active case finding for expedite diagnosis; AFB microscopy of sputum smears of all identified TB suspects; Culture is not universal, but is available according the following criteria: retreatment after relapse or drop-out, HIV/TB coinfected patients, institutional patients (penal, homeless shelters, long-term hospitals, old age homes) and health-care professionals; DOT for all patients, incentives for those adhering to regular treatment, IPT for household contacts; Information System on line; Quarterly meetings for evaluation and monitoring of activities and indicators of Tuberculosis Control Programme (TCP); Annual meeting to award prizes to units with the best results in TCP performance; Elaboration and distribution of the Yearly Epidemilogical Bulletin for TB situation up-dating; Training of health-care professionals in DOTS; Partnership with STD/AIDS Control Programme, Social Assistance Secretariat and Penitentiary System; Advocacy and Social Mobilization Meetings, organization and participation in meetings to discuss TB patients legal rights, create awareness of communitary and religious leaders to disseminate TB information.
Drug-Resistant TB: Surveillance and monitoring of multidrug resistance regarding to treatment schedule accuracy, patient follow-up and information system notification; Improvement of service network for drug-resistance attendance; Training of health-care professionals in drug-resistant patients; organization and monitoring drug distribution to MDR patients.
TB-HIV: Improving of the attending network with the partnership of AIDS Control Programme; Training of professionals in conducting tuberculin testing; Expansion of HIV testing; Implementation of IPT (isoniazide preventive therapy); Training of physicians to attend coinfected patients (TB/HIV) with drug resistant TB; Expansion of DOT procedures.
Laboratory Strengthening: Training of laboratory personnel for afb microscopy testing; Laboratory network composed of 49 units, all submitted to external quality control; From the above network, 28 units also produce micobacteria cultures; One central laboratory perform identification and susceptibility testing.
New Diagnostics: Liquid media for micobacteria culture and implantation of rapid molecular test.
New TB Drugs: None
New TB Vaccines: None
Fundamental Research: None
Research: Tb X Diabetes |
Declaration |
Declaration of interests:
Nothing to declare.
|
Application date: |
|
Last updated: |
June 16, 2014 |
|